EcoDrugPlus

Mapk Activated Protein Kinase 5

Ensembl ID : ENSLCAG00010005187
Gene Symbol: MAPKAPK5
1 Cross references
179 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2b

Ensembl ID : ENSLCAG00010007353
Gene Symbol: MKNK2B
1 Cross references
208 Possible Orthologues:

Mcl1 Apoptosis Regulator, Bcl2 Family Member B

Ensembl ID : ENSLCAG00010004617
Gene Symbol: MCL1B
1 Cross references
211 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSLCAG00010002662
Gene Symbol: LOC108895890
3 Cross references
273 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSLCAG00010006740
Gene Symbol: LOC108895890
3 Cross references
273 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSLCAG00010002448
Gene Symbol: MET
1 Cross references
205 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog (S. Cerevisiae)

Ensembl ID : ENSLCAG00010028096
Gene Symbol: LOC108890786
4 Cross references
198 Possible Orthologues:

N-Acetylated Alpha-Linked Acidic Dipeptidase 2

Ensembl ID : ENSLCAG00010021505
Gene Symbol: NAALAD2
1 Cross references
339 Possible Orthologues:

Nadph Oxidase 4

Ensembl ID : ENSLCAG00010021616
Gene Symbol: NOX4
2 Cross references
151 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSLCAG00010024981
Gene Symbol: NPC1L1
4 Cross references
189 Possible Orthologues:

P2x Purinoceptor 4

Ensembl ID : ENSLCAG00010007049
Gene Symbol: LOC108881637
4 Cross references
191 Possible Orthologues:

P2y Purinoceptor 12

Ensembl ID : ENSLCAG00010002583
Gene Symbol: LOC108900883
4 Cross references
180 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).